17 T’chelet Street
Misgav, Israel
info@PregnanTech.com
+972.52.823.6669
PregnanTech’s diverse team brings extensive expertise across various fields, including obstetrics and gynecology, medical device development, clinical research and management, regulatory compliance, business management, finance and investment, as well as communication and social impact
He holds an executive MBA from the Kellogg-Recanati Business School and a MSc in Biomedical Engineering from the Technion-Israel Institute of Technology.
Prior to leading PregnanTech, David was the medical director of multidisciplinary collaboration platforms at Sheba Medical Center, assigned to proactively align physicians and engineers from the Israeli medical industry and academia to develop cost-effective, innovative medical technology solutions to meet pressing clinical problems. He has extensive experience in inventing, innovating and developing new medical technologies.
at the Weizmann Institute of Science. She also holds an MSc, cum laude, from Tel Aviv University.
Dr. Kardish previously served as CEO of Clal Life Sciences, an R&D center supporting emerging life sciences companies; CEO of UroGyn; and Business Development Manager at Rafael Development Corporation. She joined The Trendlines Group’s management team in 2011 and subsequently served as CEO of Trendlines Incubators Israel and Vice President of The Trendlines Group.
Dr. Kardish brings more than three decades of leadership experience across the HealthTech and AgriFoodTech sectors, with extensive expertise in venture capital, product development, technology transfer, venture building, and company scale-up.
She brings over ten years of experience in medical devices, specializing in managing international clinical trials and regulatory submissions. During her tenure in a leading regulatory affairs consulting company, Nufar has monitored and managed multiple clinical trials for a variety of medical device companies, while collaborating with medical teams worldwide.
Guy possesses significant experience both in start-ups and in large companies. As part of R&D teams he supported clinical trials side by side to product development and later established a start-up’s first production line outside of Israel. Guy also gained experience in large-scale production as part of the New-Product-Industrialization department in Philips Healthcare.
Has over 20 years of experience as a scientific consultant, working with startups and in conducting and coordinating clinical trials including in the NICU and obstetrics wards.
She is currently completing a J.D. at the University of Pennsylvania. She possesses significant knowledge on the social impact and significance of developing women’s healthcare in the United States.
more than 25 years of experience at the forefront of medical technology. She has advised companies across a broad spectrum of FDA interactions and played a pivotal role in advancing the approval of several groundbreaking medical devices.
An MIT-trained engineer with early experience in the pharmaceutical industry, Janice has built her distinguished career at the intersection of technology, regulation, and healthcare. She combines deep regulatory expertise, strategic insight, and a lifelong passion for science and innovation to help companies navigate complex FDA pathways and bring transformative technologies to patients.
He has authored over 600 peer-reviewed scientific manuscripts and is the editor of many medical textbooks in Obstetrics. Prof. Berghella has been a member and chairman of several committees of the American College of Obstetrics and Gynecology (ACOG), is an Oral Examiner for the American Board of Obstetrics and Gynecology (ABOG) and is Past-President of the Society for Maternal-Fetal Medicine (SMFM). He is Editor in Chief of the American Journal of Obstetrics and Gynecology MFM (AJOG MFM), Deputy Editor at UpToDate, and Associate Editor for the Cochrane Review. His research specializes in high-risk pregnancies and the prediction and prevention of preterm birth in particular.
She is a managing partner of SteelSky Ventures LLC, an investing member in the SeaChange Fund, Portfolia's Femtech Fund, Sage Growth Capital and Pipeline Angels. Her professional background includes numerous roles in corporate banking, risk management, project management and healthcare. Buffy serves on the board of the Virginia Mason Memorial Hospital and the Washington State Hospital Association. She earned an MST from Oregon Graduate Institute of Science & Technology and BS in Psychology & Biology from Pacific University.
Prof. Schiff headed Sheba's high-risk obstetrics and prenatal services departments. He has published over 100 academic papers in his field. Prof. Schiff has extensive experience in managing medical organizations with large teams, experience as CEO and COO of technology startup companies. He has healthy relationships with the VC industry and experience as a director and investor in several other biotech innovative start-up companies in the computational and pharma fields.